These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines. Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411 [TBL] [Abstract][Full Text] [Related]
5. Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines. Qashou E; Al-Hiari Y; Kasabri V; AlBashiti R; AlAlawi S; Telfah A; AlHadid A Asian Pac J Cancer Prev; 2022 May; 23(5):1529-1537. PubMed ID: 35633535 [TBL] [Abstract][Full Text] [Related]
6. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors. Deng X; Han L; Zhou J; Zhang H; Li Q Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096 [TBL] [Abstract][Full Text] [Related]
7. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays. Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596 [TBL] [Abstract][Full Text] [Related]
8. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening. Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of aminocoumarin derivatives as DPP-IV inhibitors and anticancer agents. Soni R; Soman SS Bioorg Chem; 2018 Sep; 79():277-284. PubMed ID: 29783098 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors. Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors. Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053 [TBL] [Abstract][Full Text] [Related]
13. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438 [TBL] [Abstract][Full Text] [Related]
14. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo. Jung E; Kim J; Kim SH; Kim S; Cho MH Eur J Pharmacol; 2014 Dec; 744():98-102. PubMed ID: 25448307 [TBL] [Abstract][Full Text] [Related]
15. Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate. Liu R; Zhou L; Zhang Y; Sheng NJ; Wang ZK; Wu TZ; Wang XZ; Wu H Molecules; 2017 Oct; 22(10):. PubMed ID: 29027968 [TBL] [Abstract][Full Text] [Related]
17. Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines. Salih MAF; Al-Hiari Y; Kasabri V; Darwish R; Abumansour H; Bourghli L; Al Alawi S; Albashiti R Asian Pac J Cancer Prev; 2022 Jul; 23(7):2507-2521. PubMed ID: 35901360 [TBL] [Abstract][Full Text] [Related]
18. Ephedrine as a lead compound for the development of new DPP-IV inhibitors. Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693 [TBL] [Abstract][Full Text] [Related]